2019
DOI: 10.1002/jcb.27435
|View full text |Cite
|
Sign up to set email alerts
|

LINC00461 promotes cell migration and invasion in breast cancer through miR‐30a‐5p/integrin β3 axis

Abstract: Mounting evidence has demonstrated that long noncoding RNAs (lncRNAs) are dysregulated and implicated in the occurrence and development of a wide range of human malignancies. LINC00461, a novel cancer‐related lncRNA, has been reported to be highly expressed and serve as oncogene in glioma; however, its biological role in breast cancer (BC) remains obscure. This study aimed to explore the role of LINC00461 in BC and elucidate the potential molecular mechanisms involved. In the current study, LINC00461 was found… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
37
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(39 citation statements)
references
References 40 publications
1
37
1
Order By: Relevance
“…After 60-min blocking at 25°C using 5% BSA, the membranes were incubated at 4°C with the indicated primary antibody overnight. The primary antibody against: RAP2A (ab49685, Abcam, 1:1000), AKT (ab8805, Abcam, 1:1000) [45], phosphor AKT (ab38449, Abcam, 1:1000) [46], and GAPDH (ab8245, Abcam, 1:2500) were used. Subsequently, a 60 min of incubation of the membranes at 25°C was done with the goat anti-rabbit/mouse IgG secondary antibodies, as appropriate.…”
Section: Western Blotting (Wb)mentioning
confidence: 99%
“…After 60-min blocking at 25°C using 5% BSA, the membranes were incubated at 4°C with the indicated primary antibody overnight. The primary antibody against: RAP2A (ab49685, Abcam, 1:1000), AKT (ab8805, Abcam, 1:1000) [45], phosphor AKT (ab38449, Abcam, 1:1000) [46], and GAPDH (ab8245, Abcam, 1:2500) were used. Subsequently, a 60 min of incubation of the membranes at 25°C was done with the goat anti-rabbit/mouse IgG secondary antibodies, as appropriate.…”
Section: Western Blotting (Wb)mentioning
confidence: 99%
“…Mounting studies have suggested the significant role of lncRNAs in the development of cancers, including NSCLC [14][15][16]. Herein, we selected LINC00461 for investigation because it has been demonstrated as an oncogene in multiple cancers, such as breast cancer, myeloma, and glioma [17][18][19]. In the present study, we firstly found that LINC00461 was up-regulated in NSCLC, and indicated poor prognosis.…”
Section: Discussionmentioning
confidence: 65%
“…The effect of lncRNAs on NSCLC has also been uncovered by mounting researches [14][15][16]. Long intergenic non-protein coding RNA 461 (LINC00461) demonstrated oncogenic performance in breast cancer, myeloma, and glioma [17][18][19], promoting cell growth, migration, and invasion, but it is not researched in NSCLC.…”
Section: Introductionmentioning
confidence: 99%
“…In the present study, we downloaded the data of gene and miRNA expression quantification from the TCGA-BRCA dataset, and identified DEGs, DElncR-NAs and DEmiRNAs, finding that LINC00461 exhibited a much higher expression in breast cancer. Given that LINC00416 has been reported to be able to promote cell invasion and migration in breast cancer [11], we made some further steps for validation. In addition, it has been revealed that LINC00461 can mediate cell invasion and migration in hepatocellular carcinoma via serving as a ceRNA that can competitively bind to miR-149-5p [10].…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have described that LINC00461 is a vital player in glioma progression responsible for mediating cell proliferation, invasion and migration via MAPK/ERK, PI3K/AKT and other possible signaling pathways [9], and it can be involved in the LINC00461/miR-149-5p/LRIG2 axis in turn participating in the progression of hepatocellular carcinoma [10]. However, the role of LINC00461 in breast cancer is poorly reported [11].…”
Section: Introductionmentioning
confidence: 99%